ZFP161 promotes colorectal cancer progression by transcriptionally activating c-MYC

Zinc Finger Protein 161 (ZFP161) is a key regulator of Ataxia Telangiectasia and Rad3-related (ATR) signaling, playing a crucial role in maintaining genomic stability. Human ZFP161 activates <i>c-MYC</i>, whereas its murine ortholog, ZF5, serves as a putative transcriptional repressor of <i>c-MYC</i>. In this study, we identified ZFP161 as a direct regulator of c-MYC. We show that ZFP161 binds to the promoter region of <i>c-MYC</i>, modulating its expression and downstream signaling pathways. Additionally, ZFP161 promotes cell proliferation and tumorigenesis through c-MYC regulation and contributes to the malignant transformation of non-cancerous retinal pigment epithelial (RPE-1) cells. Furthermore, high <i>ZFP161</i> expression is associated with poor survival in patients with mixed colon adenocarcinoma. These findings suggest that the regulation of <i>c-MYC</i> by ZFP161 may represent a potential therapeutic target in <i>c-MYC</i>-driven cancers.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-02-18
DOI
https://doi.org/10.3389/fonc.2025.1680561
Primary Topic
DNA Repair Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ZFP161 promotes colorectal cancer progression by transcriptionally activating c-MYC

Chenghui Cai, W. J. Kim, Grania Christyani, Xinyi Tu et al.
Frontiers in Oncology
DNA Repair Mechanisms
article

ZFP161 promotes colorectal cancer progression by transcriptionally activating c-MYC

Chenghui Cai, W. J. Kim, Grania Christyani, Xinyi Tu, Zhenkun Lou, Hyorin Lee, Chao Zhang, Yening Feng
article en

Abstract

Zinc Finger Protein 161 (ZFP161) is a key regulator of Ataxia Telangiectasia and Rad3-related (ATR) signaling, playing a crucial role in maintaining genomic stability. Human ZFP161 activates <i>c-MYC</i>, whereas its murine ortholog, ZF5, serves as a putative transcriptional repressor of <i>c-MYC</i>. In this study, we identified ZFP161 as a direct regulator of c-MYC. We show that ZFP161 binds to the promoter region of <i>c-MYC</i>, modulating its expression and downstream signaling pathways. Additionally, ZFP161 promotes cell proliferation and tumorigenesis through c-MYC regulation and contributes to the malignant transformation of non-cancerous retinal pigment epithelial (RPE-1) cells. Furthermore, high <i>ZFP161</i> expression is associated with poor survival in patients with mixed colon adenocarcinoma. These findings suggest that the regulation of <i>c-MYC</i> by ZFP161 may represent a potential therapeutic target in <i>c-MYC</i>-driven cancers.

Frontiers in OncologyVol. 15
Hunan University (CN), Soonchunhyang University (KR), Mayo Clinic in Arizona (US)
Mayo Foundation for Medical Education and Research, National Research Foundation, Soonchunhyang University, National Research Foundation of Korea
No poverty
Openalex Percentile: Top 51%
DNA Repair Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ZFP161 promotes colorectal cancer progression by transcriptionally activating c-MYC — Chenghui Cai, W. J. Kim, et al. · Frontiers in Oncology (2026) | TGRS Research Map | TGRS